Search Results - "Khamesipour, A."

The importance of the patient voice in vaccination and vaccine safety—are we listening? by Holt, D., Bouder, F., Elemuwa, C., Gaedicke, G., Khamesipour, A., Kisler, B., Kochhar, S., Kutalek, R., Maurer, W., Obermeier, P., Seeber, L., Trusko, B., Gould, S., Rath, B.

“…Much has been written about the patient–physician relationship over the years. This relationship is essential in maintaining trust in the complex arena of…”
Get full text

Refugee health and the risk of cutaneous Leishmaniasis in Europe by Khamesipour, A, Rath, B

Get full text

Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: A study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum by Elikaee, S., Zarei, Z., Khamesipour, A., Akhoundi, B., Borjian, A.R., Afshar, M. J. Abbaszadeh, Allely, Q.K., Heidari, S., Mohebali, M.

“…•Lmp27−/− mutant as a vaccine candidate is safe in dogs.•Lmp27−/− mutant induces protective immunity against heterologous challenge in dogs.•Lmp27−/− mutant as…”
Get full text

PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model by Naseri, H., Eskandari, F., Jaafari, M. R., Khamesipour, A., Abbasi, A., Badiee, A.

“…Summary Although there have been several attempts to develop a vaccine against leishmaniasis, no vaccine in human has been developed yet. Liposomes consisting…”
Get full text

Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice by Moosavian Kalat, S.A., Khamesipour, A., Bavarsad, N., Fallah, M., Khashayarmanesh, Z., Feizi, E., Neghabi, K., Abbasi, A., Jaafari, M.R.

“…[Display omitted] •Topical liposomal Glucantime reduced lesion sizes in BALB/c model of leishmaniasis.•The spleen parasite burden was significantly lower in…”
Get full text

Tumour Necrosis Factor‐alpha (TNF‐α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases by Nateghi Rostami, M., Seyyedan Jasbi, E., Khamesipour, A., Mohammadi, A. M.

“…Summary The role of tumour necrosis factor‐alpha (TNF‐α) is not fully understood in human leishmaniasis. We analysed the alterations in the levels of TNF‐α,…”
Get full text

TLR2 and TLR4 in Cutaneous Leishmaniasis Caused by Leishmania major by Tolouei, S., Hejazi, S. H., Ghaedi, K., Khamesipour, A., Hasheminia, S. J.

“…Cutaneous leishmaniasis (CL) is a self‐healing skin disease which rarely for unknown reason(s) the lesion develops to a non‐healing form. It seems that the…”
Get full text

Hepatoprotective and antioxidant effects of Hedera helix extract on acetaminophen induced oxidative stress and hepatotoxicity in mice by Moshaie-Nezhad, P, Faed Maleki, F, Hosseini, S M, Yahyapour, M, Iman, M, Khamesipour, A

“…Exposure to high doses of acetaminophen is the most common cause of drug induced liver injury. We investigated the protective effects of extract against…”
Get more information

Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation by Lieke, T, Nylén, S, Eidsmo, L, McMaster, W.R, Mohammadi, A.M, Khamesipour, A, Berg, L, Akuffo, H

“…Natural killer (NK) cells contribute to immunity as the first line of defence in numerous infections by early cytokine secretion and cytotoxicity. In…”
Get full text

Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice by Jabini, R, Jaafari, M R, Vahdati Hasani, F, Ghazizadeh, F, Khamesipour, A, Karimi, G

“…Leishmania major is resistant to the traditional treatments in many parts of the world. PgpA, a member of (ABC) transporter superfamily, has been identified in…”
Get more information

Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity by Daneshpazhooh, M, Chams-Davatchi, C, Khamesipour, A, Mansoori, P, Taheri, A, Firooz, A, Mortazavi, H, Esmaili, N, Dowlati, Y

“…Background  Pemphigus vulgaris (PV) is a chronic autoimmune blistering disorder of the skin and mucosa characterized by the presence of autoantibodies against…”
Get full text

Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran by Akhavan, A.A., Yaghoobi-Ershadi, M.R., Khamesipour, A., Mirhendi, H., Alimohammadian, M.H., Rassi, Y., Arandian, M.H., Jafari, R., Abdoli, H., Shareghi, N., Ghanei, M., Jalali-zand, N.

“…Zoonotic cutaneous leishmaniasis (ZCL) due to Leishmania major is a great public health problem in the Old World. Leishmania major is widely distributed in…”
Get full text

Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs by Hadighi, R, Boucher, P, Khamesipour, A, Meamar, A. R, Roy, G, Ouellette, M, Mohebali, M

“…Cutaneous leishmaniasis (CL) is a major health problem in endemic areas of Iran. The pentavalent antimony (SbV) based drug Glucantime is the first line of…”
Get full text

Condensed hyperelements method of non-vertical consistent boundaries for wave propagation analysis in irregular media by Dorafshan, S., Behnamfar, F., Khamesipour, A., Motosaka, M.

“…The study of wave propagation in finite/infinite media has many applications in geotechnical and structural earthquake engineering and has been a focus of…”
Get full text

Plasma levels of tumor necrosis factor-alpha (TNF-α), TNF-α soluble receptor type 1 (sTNFR I) and IL-22 in human leishmaniasis by Nateghi Rostami, M, Seyyedan Jasbi, E, Khamesipour, A, Miramin Mohammadi, A

“…The role of pro-inammatory cytokine tumor necrosis factor-alpha (TNF-α) in human leishmaniasis is not fully understood. We analyzed the alterations in the…”
Get more information

Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins by Tafaghodi, M, Eskandari, M, Kharazizadeh, M, Khamesipour, A, Jaafari, M R

“…Immune responses against the Leishmania antigens are not sufficient to protect against a leishmania challenge. Therefore these antigens need to be potentiated…”
Get full text

A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis by Nassiri-Kashani, M, Firooz, A, Khamesipour, A, Mojtahed, F, Nilforoushzadeh, M, Hejazi, H, Bouzari, N, Dowlati, Y

“…ABSTRACT Background  Several modalities have been used for the treatment of cutaneous leishmaniasis (CL) with various results. In vitro and in vivo studies…”
Get full text

Interleukin 4 (IL-4) gene promoter polymorphisms in Rhombomys opimus, the main reservoir of zoonotic cutaneous leishmaniasis by Bakhshi, H., Borhani, N., Mohebali, M., Khamesipour, A., Abai, M.R., Hajjaran, H., Tajedin, L., Rassi, Y., Akhavan, A.A., Mohtarami, F., Oshaghi, M.A.

“…[Display omitted] •Great gerbils are the main reservoir of cutaneous leishmaniasis (CL) due to Leishmania major.•We designed specific primers to amplify IL-4…”
Get full text

IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis by Tolouei, S, Ghaedi, K, Khamesipour, A, Akbari, M, Baghaei, M, Hasheminia, Sj, Narimani, M, Hejazi, Sh

“…In this study the level of IL-23 and IL-27 produced by macrophages derived from peripheral blood mononuclear cell culture collected from patients with healing…”
Get full text

Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct by Kheirandish, F, Bandehpour, M, Davoudi, N, Mosaffa, N, Dawood, S, Kazemi, B, Haghighi, A, Khamesipour, A, Masjedi, H, Mohebali, M, Mahboudi, F

“…Pteridine metabolic pathway is unusual features of Leishmania, which is necessary for the growth of parasite. Leishmania has evolved a complex and versatile…”
Get full text